Q-Bank Breakdown: CKD stages and GFR — Why Every Answer Choice Matters

You’re cruising through a renal question, you see a creatinine and an eGFR, and suddenly every answer choice looks “kind of right.” That’s exactly why CKD staging shows up so often on Step 1/2: it’s not just memorizing cutoffs—it’s recognizing what those cutoffs mean, what else must be present to diagnose CKD, and which complications to expect at each stage.

Tag: Renal > Acute Kidney Injury & CKD

---

The vignette (classic CKD staging trap)

A 62-year-old man with long-standing type 2 diabetes and hypertension comes to clinic for routine follow-up. He feels well. BP is 148/86 mm Hg. Labs show:

• Serum creatinine: 1.8 mg/dL (baseline 1.7–1.9 over the past year)
• eGFR: 42 mL/min/1.73 m² (persistently in the 40s for 8 months)
• Urine albumin-to-creatinine ratio (UACR): 220 mg/g
• Potassium: 4.6 mEq/L
• Bicarbonate: 22 mEq/L

Which of the following best describes his kidney disease?

A. CKD stage 3a
B. CKD stage 2
C. CKD stage 3b
D. Acute kidney injury
E. End-stage kidney disease (CKD stage 5)

---

Step-by-step: What’s the diagnosis and why?

1) First decide: CKD vs AKI

CKD requires abnormalities of kidney structure or function for $\ge 3$ months with health implications. This patient has:

• Reduced eGFR (42) for 8 months
• Albuminuria (UACR 220 mg/g) = kidney damage marker

That is CKD, not AKI.

2) Then stage by eGFR

CKD GFR categories (KDIGO):

An eGFR of 42 falls in G3b (30–44).

✅ Correct answer: C. CKD stage 3b

---

Now crush the distractors (why each wrong answer is wrong)

A. CKD stage 3a — tempting, but the cutoff matters

• 3a is 45–59, and he’s at 42.
• Q-banks love values near boundaries because CKD staging affects:
  • follow-up frequency
  • complication risk (anemia, mineral bone disease, acidosis)
  • medication dosing and contrast decisions

Rule: If they give you an eGFR in the low 40s, think 3b, not 3a.

---

B. CKD stage 2 — you’re ignoring the GFR range

Stage 2 requires eGFR 60–89 plus evidence of kidney damage (e.g., albuminuria).
He does have albuminuria, but his eGFR is far below 60, so stage 2 is incorrect.

High-yield nuance:

• Albuminuria can diagnose CKD even when eGFR is normal (G1/G2), as long as it persists for $\ge 3$ months.

---

D. Acute kidney injury — AKI is about timing and change

AKI is defined by abrupt decline (hours to days), commonly operationalized as:

• Increase in creatinine by $\ge 0.3$ mg/dL within 48 hours, or
• Increase to $\ge 1.5\times$ baseline within 7 days, or
• Urine output <0.5 mL/kg/hr for 6 hours

Here, creatinine and eGFR are stable over months, and he’s asymptomatic.

Exam move: If the stem says “baseline is X” and current is about the same over months → CKD.
If there’s a sudden bump relative to baseline → consider AKI on CKD (a favorite hybrid).

---

E. End-stage kidney disease (CKD stage 5) — way too advanced

Stage 5 is eGFR <15, often with uremic symptoms and/or dialysis planning.

At eGFR 42, he may have early complications, but he is nowhere near ESRD.

High-yield: “ESRD” in test questions often implies dialysis requirement (not just “bad kidneys”).

---

Don’t stop at staging: add albuminuria (USMLE loves this)

Albuminuria categories:

His UACR is 220 mg/g → A2.

So you can describe him as: CKD G3b A2 (diabetic kidney disease pattern is common).

Why it matters: Higher albuminuria predicts:

• faster CKD progression
• higher cardiovascular risk
• greater benefit from ACEi/ARB (and SGLT2 inhibitors in many patients)

---

High-yield CKD staging associations (what to expect as GFR falls)

Complications by stage (board-style pattern recognition)

Clinical pearl: G3b is often where questions start layering in anemia and early acidosis, especially if they want you to anticipate next steps in evaluation (CBC, iron studies, bicarbonate, PTH/phosphate/vit D).

---

Q-bank habits: how they make CKD questions harder than they look

1) They mix up GFR vs creatinine

Creatinine is affected by:

• muscle mass (low muscle → deceptively low Cr)
• drugs that block tubular secretion (e.g., trimethoprim, cimetidine) → Cr rises without true GFR drop
• diet and hydration changes

If they give eGFR, use it for staging. If not, you may need to interpret creatinine in context.

2) They test the “CKD requires 3 months” rule

• A single low eGFR does not equal CKD.
• You need duration or supportive evidence (prior labs, imaging with small echogenic kidneys, longstanding albuminuria, etc.).

3) They sneak in AKI on CKD

If baseline Cr is elevated and then suddenly rises:

• You still have CKD and an AKI event.
• Management often starts with AKI workup (volume status, meds, obstruction) while acknowledging chronic disease.

---

Rapid-fire: what to do with CKD in real life (and on Step)

For a patient like this (CKD G3b A2, diabetes/HTN), high-yield management themes include:

• BP control (often target <130/80 if albuminuria; varies by guideline and patient context)
• ACE inhibitor or ARB for albuminuria (watch K⁺ and creatinine rise)
• SGLT2 inhibitor (renal + CV benefit in many with diabetes/CKD; Step 2 increasingly tests this concept)
• Avoid nephrotoxins (NSAIDs, iodinated contrast when possible; dose-adjust meds)
• Screen/manage complications:
  • CBC for anemia, iron studies if anemic
  • BMP for K⁺/HCO₃⁻
  • Phos, Ca, PTH, vitamin D as CKD progresses

---

Take-home points (the test-day checklist)

• CKD = $\ge 3$ months of ↓GFR and/or kidney damage (e.g., albuminuria).
• Stage CKD by eGFR:
  • 3a: 45–59
  • 3b: 30–44
• Always interpret albuminuria (A1/A2/A3); it changes prognosis and therapy.
• AKI is about rapid change, not just “bad numbers.”